The pituitary tumour epigenome: aberrations and prospects for targeted therapy
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The pituitary tumour epigenome: aberrations and prospects for targeted therapy
Authors
Keywords
-
Journal
Nature Reviews Endocrinology
Volume 8, Issue 8, Pages 486-494
Publisher
Springer Nature
Online
2012-04-24
DOI
10.1038/nrendo.2012.54
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
- (2011) Shlomo Melmed et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cancer epigenetics reaches mainstream oncology
- (2011) Manuel Rodríguez-Paredes et al. NATURE MEDICINE
- Medical therapy in acromegaly
- (2011) Mark Sherlock et al. Nature Reviews Endocrinology
- Pathogenesis of pituitary tumors
- (2011) Shlomo Melmed Nature Reviews Endocrinology
- Epigenetic cancer therapy: Proof of concept and remaining challenges
- (2010) Cora Mund et al. BIOESSAYS
- Aberrant Epigenetic Landscape in Cancer: How Cellular Identity Goes Awry
- (2010) María Berdasco et al. DEVELOPMENTAL CELL
- Reversal of Endogenous Dopamine Receptor Silencing in Pituitary Cells Augments Receptor-Mediated Apoptosis
- (2010) Haneen Al-Azzawi et al. ENDOCRINOLOGY
- 5-azacytidine treatment reorganizes genomic histone modification patterns
- (2010) Vitalina M. Komashko et al. Epigenetics
- Pituitary tumours: The sst/D2 receptors as molecular targets
- (2010) Leo J. Hofland et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- HMGA2: A pituitary tumour subtype-specific oncogene?
- (2010) Monica Fedele et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Epigenetic modifications as therapeutic targets
- (2010) Theresa K Kelly et al. NATURE BIOTECHNOLOGY
- Bromocriptine and Dopamine Mediate Independent and Synergistic Apoptotic Pathways in Pituitary Cells
- (2010) F.B. Rowther et al. NEUROENDOCRINOLOGY
- Targeting DNA methylation for epigenetic therapy
- (2010) Xiaojing Yang et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Epigenetics in cancer
- (2009) S. Sharma et al. CARCINOGENESIS
- Loss of neuronatin expression is associated with promoter hypermethylation in pituitary adenoma
- (2009) K Revill et al. ENDOCRINE-RELATED CANCER
- Epigenetics and cancer treatment
- (2009) Lasse Sommer Kristensen et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Pituitary tumours: all silent on the epigenetics front
- (2009) K J Dudley et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
- (2009) Pierre Fenaux et al. LANCET ONCOLOGY
- The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells
- (2009) C Flotho et al. LEUKEMIA
- Fibroblast Growth Factor 2 and Estrogen Control the Balance of Histone 3 Modifications Targeting MAGE-A3 in Pituitary Neoplasia
- (2008) X. Zhu et al. CLINICAL CANCER RESEARCH
- Epi-drugs to fight cancer: From chemistry to cancer treatment, the road ahead
- (2008) Antonello Mai et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Deoxyribonucleic Acid Methyltransferase 3B Promotes Epigenetic Silencing through Histone 3 Chromatin Modifications in Pituitary Cells
- (2008) Xuegong Zhu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Genome-Wide Analysis in a Murine Dnmt1 Knockdown Model Identifies Epigenetically Silenced Genes in Primary Human Pituitary Tumors
- (2008) K. J. Dudley et al. MOLECULAR CANCER RESEARCH
- Chromatin, cancer and drug therapies
- (2008) Connie C. Cortez et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation
- (2008) Yutaka Kondo et al. NATURE GENETICS
- Dopamine D2 receptor gene polymorphisms and response to cabergoline therapy in patients with prolactin-secreting pituitary adenomas
- (2008) M Filopanti et al. PHARMACOGENOMICS JOURNAL
- p21Cip1 restrains pituitary tumor growth
- (2008) V. Chesnokova et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started